Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infection
Abstract Campylobacter jejuni infections are progressively increasing worldwide. Probiotic treatment might open novel therapeutic or even prophylactic approaches to combat campylobacteriosis. In the present study secondary abiotic mice were generated by broad-spectrum antibiotic treatment and perora...
Guardado en:
Autores principales: | Stefan Bereswill, Ira Ekmekciu, Ulrike Escher, Ulrike Fiebiger, Kerstin Stingl, Markus M. Heimesaat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e06fea404814f04acdbf4298dc594af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells.
por: Jiannan Cui, et al.
Publicado: (2021) -
Genome-wide insights into population structure and host specificity of Campylobacter jejuni
por: Lennard Epping, et al.
Publicado: (2021) -
Spontaneous mutation reveals influence of exopolysaccharide on Lactobacillus johnsonii surface characteristics.
por: Nikki Horn, et al.
Publicado: (2013) -
REGULACIÓN DE LA MICROBIOTA INTESTINAL EN VOLUNTARIOS SANOS MEDIANTE EL CONSUMO DE UN PRODUCTO CON EL PROBIÓTICO Lactobacillus johnsonii La1
por: Gotteland R,Martin, et al.
Publicado: (2006) -
Distribución de biovares de Campylobacter jejuni ssp. jejuni y Campylobacter coli en monos de Iquitos (Perú)
por: TRESIERRA-AYALA,A., et al.
Publicado: (1997)